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Growing levels of microbial resistance to chemotherapeutic agents pose a threat to public health and 
constitute a global problem. The above can be often attributed to improper and excessive use of antibacteri-
al drugs in veterinary and human medicine, animal breeding, agriculture and industry. To address this 
problem, veterinary and human health practitioners, animal breeders and the public have to be made aware 
of the consequences and threats associated with the uncontrolled use of antibacterial preparations. In 
recent years, many countries have implemented programs for monitoring antibiotic resistance which pro-
vide valuable information about the applied antibiotics and the resistance of various bacterial species 
colonizing livestock, poultry and the environment. Special attention should be paid to the sources and 
transmission routes of antibiotic resistance. There are no easy solutions to this highly complex problem. The 
relevant measures should address multiple factors, beginning from rational and controlled use of chemo-
therapeutic agents in veterinary practice, to biosecurity in animal farms, food production hygiene, and 
sanitary and veterinary inspections in the food chain. The tissues of treated birds should not contain antibi-
otic residues upon slaughter. Rational use of antibiotics should minimize the risk of drug resistance and 
decrease treatment costs without compromising the efficacy of treatment. Therefore, the key principles of 
antibiotic therapy of bacterial infections in poultry should be the adequate selection and dosage of the 
administered drug, a sound knowledge of the drug’s pharmacokinetic and pharmacodynamic properties, as 
well as a knowledge of the differences between bacteriostatic and bactericidal drugs and between time-
dependent and concentration-dependent drugs. There is an urgent need to revise the existing approach to 
the use of chemotherapeutic agents in the treatment of poultry diseases, and to increase the awareness that 
antibiotics cannot compensate for the failure to observe the fundamental principles of biosecurity in all 
stages of poultry farming. 
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In view of the growing levels of antimicrobial re-
sistance in poultry pathogens, veterinary practitioners are 
faced with the difficult task of selecting the most effective 
therapeutic method, including the drug and its dosage. 
Antibiotic resistance in microorganisms can be largely 
attributed to improper and excessive use of antibacterial 
drugs in veterinary and human medicine, animal breeding, 
agriculture and industry. This problem poses a serious 
public health hazard, and it has been addressed by the 
World Organization for Animal Health, the Food and 
Agriculture Organization of the United Nations, the 
World Health Organization and the European Parliament 
(Truszczyński and Pejsak, 2013a). Efforts are being made 
to develop an EU-wide plan for combating bacterial re-
sistance to antimicrobial drugs. Veterinary and human 
health practitioners, animal breeders and the public have 
to be made aware of the consequences and threats associ-
ated with the uncontrolled use of antibacterial prepara-
tions and effective methods of preventing drug resistance. 
It should be stressed that irrational antibiotic use without 
prior identification of the etiological factor and its sensi-
tivity to chemotherapeutic agents exerts an adverse effect 
on the immune system, eliminates healthy gut bacteria 
and often leads to treatment failure. In treated birds, re-
covery is largely determined by effective immune re-
sponses which are often compromised by previous or 
ongoing infections with immunosuppressive pathogens, 
errors in production technology, absence of biosecurity or 
the use of antibiotics with strong immunosuppressive 
effects (Tykałowski et al. 2013a).  
In recent years, many countries have implemented 
programs for monitoring antibiotic resistance which pro-
vide valuable information about the applied antibiotics 
and the resistance of various bacterial species colonizing 
livestock, poultry and the environment (EFSA, 2010, 
2012, 2013; Truszczyński and Pejsak, 2013b). The alarm-
ing rise in bacterial resistance to drugs has been described 
extensively by (Truszczyński and Pejsak, 2011; 
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Truszczyński and Pejsak, 2013a; Truszczyński and 
Pejsak, 2013b), with special emphasis on the source and 
transmission routes of antibiotic resistance. There are no 
easy solutions to this highly complex problem. The rele-
vant measures should address multiple factors, beginning 
from rational and responsible use of antibiotics and 
chemotherapeutic agents in human and veterinary medi-
cine, to biosecurity in animal farms, food production 
hygiene, and sanitary and veterinary inspections in the 
food chain. 
Recent research points to a steady increase in the 
number of resistant strains in pathogenic microorganisms 
that are most frequently isolated from birds and require 
treatment with veterinary drugs (Koncicki, 2013). The 
above also applies to zoonotic bacteria, including Cam-
pylobacter spp. (Woźniak and Wieliczko, 2009; Woźniak 
et al., 2013; Wieczorek and Osek, 2013; Koncicki et al., 
2015) and Salmonella spp. (Threlfall et al., 2006). These 
zoonotic bacteria are pathogenic for humans, and poultry 
and poultry meat are the main reservoirs of these micro-
organisms. Escherichia coli causes the greatest losses in 
poultry production, and E. coli infections are mostly 
commonly treated with fluoroquinolones, polymyxins and 
β-lactam antibiotics (Kuczkowski et al., 2013).  
An analysis of the latest research findings indicates 
that bacteria isolated from poultry are characterized by 
growing levels to resistance to chemotherapeutic agents 
and that selected strains of resistant bacteria can be a 
source of resistance genes for other strains, which poses a 
threat to human and animal health. These problems stem 
from long-term use of antibacterial chemotherapeutic 
agents in poultry and the presence of antibiotic resistant 
bacteria and/or bacterial genes encoding antibiotic re-
sistance in human and animal habitats.   
Natural resistance is conferred by genetically condi-
tioned phenotypic traits in bacteria, such as the width of 
protein channels in cell membranes which determines an 
antibiotic molecule’s ability to penetrate a bacterial cell 
(Quinn et al., 2002). The second type of resistance is 
acquired resistance which is linked with one or more 
point mutations in chromosome or plasmid genes and the 
transfer of genes encoding antibiotic resistance to drug-
sensitive bacteria. Most importantly, genetic material is 
transferred between bacterial cells in microorganisms that 
are pathogenic for humans and animals as well as be-
tween saprophytic bacteria (Bywater et al., 2004). Hu-
mans , animals, raw materials and food products  of plant 
and animal origin, human and animal feces, wastewater, 
soil and water bodies as well as cafeterias, kitchens, food 
storage facilities and grocery shops can all act as vectors 
for the transmission of antibiotic-resistant bacteria and 
genes encoding antibiotic resistance (Woźniak and 
Wieliczko, 2009; Truszczyński and Pejsak, 2011; 
Truszczyński and Pejsak, 2013b). The presence of genes 
encoding resistance to several antibiotics in genetic mate-
rial transferred from the donor to the recipient of bacteria 
leads to multiple drug resistance (MDR) (Bywater et al., 
2004; Woźniak and Wieliczko, 2009; Truszczyński and 
Pejsak, 2013b). It should also be noted that the use of 
antibiotics as growth promoters has been banned in the 
EU, including in Poland, since 1 January 2006. However, 
antibiotics can still be used as growth promoters in animal 
production in non-EU countries (Przeniosło-Siwczyńska 
and Kwiatek, 2013). Therefore, food products imported 
from third countries can be a source of antibiotic-resistant 
bacteria and genes encoding antibiotic resistance. 
In view of the growing levels of antibiotic resistance 
in bacteria, veterinary practitioners should be made in-
creasingly aware of the need to administer chemothera-
peutic agents to poultry in a safe and rational manner and 
in strict observance of legal regulations.   
It is of utmost importance that antibiotics are adminis-
tered based on the results of an antibiogram test per-
formed on correctly sampled biological material. Antibi-
otics should be applied in early stages of disease, and 
their effectiveness should be closely monitored. However, 
it should be stressed that antibiotic therapy may involve 
initial therapy and alternating therapy (Pejsak and 
Truszczyński, 2013). The initial therapy is usually admin-
istered empirically before determining the drug sensitivity 
profile of bacteria, although veterinary practitioners often 
rely only on empirically selected antibiotics. This ap-
proach requires clinical, anatomopathological and micro-
biological knowledge (bacterial species, i.e. potential 
etiological agents of disease), experience with poultry 
diseases and access to the results of screening studies 
analyzing the antibiotic susceptibility of bacteria encoun-
tered in turkey farms and turkey farming regions. In many 
cases, the isolated bacterial strains are resistant to antibi-
otics that have never been applied in the examined farm. 
The above can be attributed to various sources and trans-
mission routes of antibiotic resistance.  
Alternating therapy may be proposed if the initial 
therapy was ineffective. The treatment may be empirical 
(if the results of an antibiogram test are not yet available) 
or targeted if the isolated bacteria’s antibiotic susceptibil-
ity profile has been reliably determined. However, the 
results of in vitro tests can differ from the in vivo perfor-
mance of an antibiotic, and not all targeted treatments are 
effective. The risk of failure should be minimized in anti-
biotic treatments addressing serious problems and large 
flocks of infected poultry.  
Veterinary practitioners should select medicinal prod-
ucts that most effectively target a given ailment, prefera-
bly based on the results of an antibiogram test (but bear-
ing in mind that in vitro results can differ from the drug’s 
performance in vivo). The determination of the drug’s 
most effective dose is a very important consideration in 
antibacterial chemotherapy. The adequate dose should be 
set based on three key criteria to minimize the spread of 
drug resistance in poultry pathogens: the drug has to be 
administered at a sufficiently high concentration, at the 
appropriate time intervals and over a sufficiently long 
period of time (Dzierżawski and Cybulski, 2012; Świtała, 
2013). The failure to observe the above principles con-
tributes not only to a rapid increase in antibiotic re-
sistance, but also to non-observance of the appropriate 
withdrawal (waiting) period. A change in the drug dosage 
recommended by the manufacturer could improve the 
efficacy of treatment, but it could also prolong the with-
drawal period. In poultry, the administered dose plays the 
key role in drug kinetics, and it influences the time (in 
days) after which the concentration of the drug decreases 
below the maximum residue limit (MRL). In the EU, the 
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MRL is the maximum concentration of residue that is 
deemed as safe for consumers by the European Medicines 
Agency (EMA). 
Veterinary practitioners have to be familiar with the 
pharmacokinetic and pharmacodynamic properties of the 
prescribed drug to determine its effective dose and mini-
mum inhibitory concentration (MIC). Based on those two 
indicators, chemotherapeutic agents for poultry can be 
divided into two groups: concentration-dependent drugs 
(enrofloxacin, flumequine, neomycin, colistin) and time-
dependent drugs (β-lactam antibiotics (amoxicillin), mac-
rolides (erythromycin, spiramycin, tilmicosin), lincosa-
mides (lincomycin), pleuromutillins (tiamulin), tetracy-
clines (doxycycline, oxytetracycline), phenicols 
(florfenicol, thiamphenicol) and sulfonamides               
(Świtała, 2013). The efficacy of concentration-dependent 
drugs is determined by their concentration in the body, 
and these antibiotics generally deliver rapid bactericidal 
effects regardless of the phase of bacterial growth (alt-
hough treatment is always more effective in the initial 
stage of infection characterized by the log phase of bacte-
rial growth). This group of chemotherapeutic drugs is 
most effective when administered in a single daily dose 
within a relatively short period of time. Time-dependent 
chemotherapeutic drugs are most effective when the daily 
dose is administered over a prolonged period of time to 
maintain effective plasma concentration (MIC) during the 
dosing interval.  
Antibiotics can also be classified as bacteriostatic 
(plasma and tissue concentrations of the drug are main-
tained above the MIC to merely inhibit the growth of 
pathogenic bacteria which are ultimately eliminated by 
the immune system) and bactericidal antibiotics (drug 
concentration can drop below the MIC). Bacteriostatic 
agents include tetracyclines, macrolides, lincosamides, 
phenicols and sulfonamides. Examples of bactericidal 
antibiotics include β-lactams, aminoglycosides, fluoro-
quinolones and polymyxins. 
Combination antibiotic therapy, where two or more 
products are used simultaneously, is yet another form of 
chemotherapy. Medical practitioners must be aware of the 
possible interactions between the prescribed combination 
of antibiotics. The administered drugs should deliver 
synergistic effects (combined antibiotics exert stronger 
effects than individual drugs). Bactericidal antibiotics 
generally exhibit synergistic effects in combined therapy, 
whereas bacteriostatic antibiotics can disrupt the bacteri-
cidal effects of an antibiotic by inhibiting microbial 
growth (bacteriostasis). Examples of combination antibi-
otic therapy include β-lactams with aminoglycosides, 
quinolones or clavulanic acid, and fluoroquinolones with 
polymyxins. Combination therapy is recommended for 
severe infections, infections with a high mortality rate and 
infections without a fully known etiology (antibiotic 
monotherapy is recommended once the infectious agent 
has been identified and subjected to an antibiogram test). 
In principle, chemotherapeutic agents with the narrowest 
possible spectrum of action that selectively target one 
type of bacteria should be used. 
In infected poultry, drugs are usually administered per 
os with water (less commonly with feed) or are delivered 
by injections or aerosols. Interactions with metal ions can 
significantly influence the efficacy of chemotherapeutic 
agents. For this reason, the quality of water administered 
with drugs should be closely inspected. Metal ions in hard 
water (calcium, magnesium, zinc, iron, copper, alumi-
num) are capable of chelating drugs, such as fluoroquin-
olones, which impairs the drug’s absorption from the 
gastrointestinal tract, decreases its bioavailability, renders 
the treatment ineffective, and may have serious clinical 
implications. The produced chelates are larger and have a 
different molecular structure than unchelated drugs. Che-
lated drugs may be unable to bind to the carrier and pene-
trate cells (Turel, 2002). Tetracyclines are very often used 
to treat infections in poultry, and their efficacy and stabil-
ity decrease when dissolved in hard water. The pH of 
water also significantly influences a drug’s solubility and 
stability; for example, amoxicillin is inactivated in an 
acidic environment. When drugs are supplied with drink-
ing water in animal farms, the water supply system should 
be clean and disinfected (free of biofilm) and dosing 
pumps should be in working order.  
Regardless of the route of drug administration, veteri-
nary practitioners should be familiar with the pharmaco-
kinetics of various chemotherapeutic agents, and should 
be able to distinguish between drugs that are poorly ab-
sorbed (colistin, neomycin, lincomycin) and well ab-
sorbed (doxycycline, tiamulin) from the gastrointestinal 
system. Veterinarians should also be aware that tetracy-
clines and tiamulin are accumulated in joints, which is a 
very important consideration in the treatment of leg disor-
ders in birds, in particular turkeys.  
Diseases caused by a single bacterial species are be-
coming increasingly rare in commercial poultry farms. In 
large-scale poultry farming, birds are commonly affected 
by syndromes that are caused by several pathogens, such 
as viruses and bacteria, under the adverse influence of 
non-infectious factors (housing and management condi-
tions, diet, stress). These types of infections are severe 
and difficult to treat. Chronic and recurring bacterial in-
fections in poultry, such as ornithobacteriosis, pose a 
considerable therapeutic problem which is difficult to 
resolve with the use of antibiotics and chemotherapeutic 
agents due to growing levels of antimicrobial resistance. 
Irrational and excessive antibiotic use without the identi-
fication of the etiological factor and its sensitivity to 
chemotherapeutic agents adversely influences the immune 
system, leads to the elimination of healthy gut flora and 
often results in treatment failure (Tykałowski et al., 
2013a; Tykałowski et al., 2013b). Birds infected with 
bacterial strains resistant to chemotherapeutic agents can 
benefit from immunomodulation as supplementary treat-
ment because their recovery is largely determined by 
immune system health (Tykałowski, 2012).  
According to current knowledge, selected antibacterial 
drugs, in particular aminoglycosides, tetracyclines and 
sulfonamides, can significantly inhibit the key immune 
mechanisms and lead to secondary immunodeficiencies 
during repeated antibiotic therapy, which increases the 
patient’s susceptibility to other infections (Tykałowski et 
al., 2013b). For this reason, antibacterial chemotherapeu-
tic agents are often used with immunomodulators to in-
crease the efficacy of treatment. Effective natural im-
munomodulators include β-glucans extracted from the 
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cell walls of Saccharomyces cerevisiae yeast, and lyso-
zyme dimers (lysozyme extracted from chicken egg white 
and subjected to dimerization). Synthetic immunomodula-
tors are also used, including levamisole (antiparasitic 
drug) and methisoprinol (isoprinosine) (Andrzejewski, 
2007; Stenzel, 2009; Tykałowski, 2012).  
In view of the above, there is an urgent need to revise 
the existing approach to the use of chemotherapeutic 
agents in the treatment of poultry diseases. The awareness 
that antibiotics cannot compensate for the failure to ob-
serve the fundamental principles of biosecurity in all 
stages of poultry farming should be spread among veteri-
nary practitioners and poultry breeders.  
The 20th century will undoubtedly be remembered as 
the era of antibiotics. However, the rapid increase in anti-
biotic resistance and the risk of veterinary drug residues 
in meat and eggs could contribute to the biologization of 
poultry production in the 21st century by encouraging the 
use of beneficial microorganisms that inhibit the growth 
of pathogens, immunomodulation, immunotherapy, phage 
therapy and phytotherapy (Koncicki et al., 2015). 
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